Question 1

What are the most cited papers from Pharmabridge (United States)?

Accepted Answer

The most cited paper from Pharmabridge (United States) is "Design, Synthesis, and Biological Evaluation of Triazolo-pyrimidine Derivatives as Novel Inhibitors of Hepatitis B Virus Surface Antigen (HBsAg) Secretion" (Wenquan Yu, Cally Goddard, Elizabeth Clearfield et al., 2011), with 122 citations. Next come "Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses" (86) and "Investigation of deltamethrin resistance in salmon lice (Lepeophtheirus salmonis) provides no evidence for roles of mutations in voltage‐gated sodium channels" (5).

Question 2

Which research topics does Pharmabridge (United States) publish most on?

Accepted Answer

By volume in 2022-now: Pharmaceutical Practices and Patient Outcomes.

Question 3

Which fields of science does Pharmabridge (United States) work in?

Accepted Answer

In all years, 50% of research at Pharmabridge (United States) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (50%), Immunology and Microbiology (25%), Biochemistry, Genetics and Molecular Biology (8%).

Question 4

Is Pharmabridge (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 0% higher than in 2018-2021.